Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
São Paulo med. j ; 136(4): 304-309, July-Aug. 2018. tab
Article in English | LILACS | ID: biblio-962732

ABSTRACT

ABSTRACT BACKGROUND: Wilson's disease (WD) may present with different manifestations: from an asymptomatic state to liver cirrhosis. Here, we aimed to evaluate clinical presentations and laboratory findings and prognoses among WD cases. DESIGN AND SETTING: Cross-sectional study based on patients' records from the university hospital, İnönü University, Malatya, Turkey. METHODS: The medical records of 64 children with WD were evaluated focusing on the clinical, laboratory and liver biopsy findings in different clinical presentations. RESULTS: The mean age at diagnosis was 8.6 ± 3.26 years (range 3.5-17) and mean length of follow-up was 2.49 years (range 0-9). There were 18 cases (28.1%), 12 (18.8%), 9 (14.1%) and 6 (9.4%) of chronic liver disease, fulminant liver failure, neurological WD and acute hepatitis, respectively. Nineteen (29.7%) were asymptomatic. The most common sign and laboratory finding were jaundice (45.3%) and hypertransaminasemia (85.9%), respectively. The lowest serum zinc level was found in the fulminant liver failure group (P = 0.035). Hepatosteatosis was detected in 35% of the 20 patients who underwent liver biopsy. Among those with hepatosteatosis, 57.1% were asymptomatic. While 35% had copper staining, 25% presented iron accumulation in liver biopsies. Nine cases underwent liver transplantation and seven of these presented fulminant liver failure (77.8%). CONCLUSION: The presentation, symptoms and signs of our cases were similar to those in previously reported series, except for the high proportion of fulminant WD cases. Further studies are needed to clarify the relationship between zinc levels and development of a fulminant course and between iron status and WD.


Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Hepatolenticular Degeneration/pathology , Prognosis , Biopsy , Acute Disease , Chronic Disease , Cross-Sectional Studies , Retrospective Studies , Hepatolenticular Degeneration/blood
3.
Acta bioquím. clín. latinoam ; 41(3): 347-351, jul.-sep. 2007. graf, tab
Article in Spanish | LILACS | ID: lil-633017

ABSTRACT

La Ceruloplasmina (Cp) es la principal proteína transportadora de cobre en circulación. Su concentración es abundante en plasma; se considera un reactante de fase aguda y su función fisiológica no se encuentra fehacientemente establecida. Fundamentalmente se sintetiza en los hepatocitos. También se encuentra en otros tipos celulares como monocitos, astrocitos y células de Sertoli. Su concentración sérica se utiliza en el diagnóstico diferencial de enfermedad de Wilson. La concentración total en plasma se considera igual a la suma de las concentraciones de apo y holo Cp, de manera que la cantidad de esta proteína determinada por un método inmunológico no indica que la enzima se encuentre presente solamente en su forma activa. Entonces, al utilizar esta metodología, se sobreestima la proteína funcionalmente activa. Existen diversos métodos para determinar su actividad. En este trabajo se describe un método automatizado para medir su actividad ferroxidasa que utiliza iones Fe2+ como sustrato. Los valores de referencia de actividad de Cp se diferenciaron estadísticamente entre el grupo de mujeres y el de hombres, siendo de 424-796 UI/L y 397-733 UI/L, respectivamente. Además, se obtuvo una correlación significativa entre la actividad ferroxidasa y la concentración proteica (r=0,7285; p<0,0001).


Ceruloplasmin (Cp) is the principal copper carrier in human plasma. It is an abundant protein that participates in the acute phase reaction to stress, but its physiological function is unknown. Althought Cp is synthesised predominantly in the liver, other cell types express the protein, including monocytes, astrocytes and Sertoli cells. The serum concentration of the copper protein ceruloplasmin has been an important diagnostic indicator of Wilson`s disease. Measurement of the total amount of Cp protein may not reflect Cp enzyme activity in the serum. The immunologic assay may lead to overestimation of the total amount of functional Cp in the serum due to this method's capacity to determine both the functional holo Cp and non-functional apo Cp. Several methods for determining ferroxidase activity have been reported. In this study, a method is described for automated measurement of the activity. In this method, Fe2+ ions are used as the substrate. The range for serum Cp ferroxidase activity in healthy persons was 424-796 UI/L for women, and 397-733 UI/L for men. Significant correlations between serum ferroxidase activity and Cp concentration (r=0,7285; p < 0,0001) were found.


Subject(s)
Humans , Ceruloplasmin/physiology , Reference Values , Ceruloplasmin/analysis , Ceruloplasmin/metabolism , Hepatolenticular Degeneration/blood
4.
Indian J Pathol Microbiol ; 2001 Jul; 44(3): 301-4
Article in English | IMSEAR | ID: sea-74145

ABSTRACT

The present study deals with a total of 28 cases of Wilson's disease, 50 normal individuals alongwith siblings and parents of eight cases. Male predominance (18 out of 28 cases), a median age of 11 years and universal presence of Kayser-Fleischer (K. F.) ring marked the cardinal features. Furthermore, 11 patients had hepatic-neural presentation while two had only the K. F. Ring without clinical abnormality. Single Radial Immunodiffusion (SRID) as the absolute quantitative procedure revealed a profound deficiency of ceruloplasmin with the levels ranging anywhere between 0.5 mg/dI to 23 mg/dI amongst the patients of Wilson's disease. The data from siblings and parents also revealed deficiency in 15 out of 23 serum samples when subjected to disc electrophoresis-benzidine screening procedure.


Subject(s)
Adolescent , Adult , Blood Protein Electrophoresis , Case-Control Studies , Ceruloplasmin/deficiency , Child , Child, Preschool , Electrophoresis, Disc , Female , Hepatolenticular Degeneration/blood , Humans , Immunodiffusion , Infant , Male
5.
Indian Pediatr ; 1991 Jul; 28(7): 779-85
Article in English | IMSEAR | ID: sea-8749
6.
Neurol. Colomb ; 4(1): 451-7, 1980. ilus
Article in Spanish | LILACS | ID: lil-72287

ABSTRACT

Se presenta el caso de una nina de 13 anos con Enfermedad de Wilson y se hace un resumen de los aspectos mas importantes de la enfermedad hepatolenticular una de las afecciones "degenerativas", cuyo trastorno del metabolismo del cobre se origina en defectos enzimaticos de la ceruloplasmina. Un hallazgo importante en este caso fueron los depositos de cobre en las encias. La escanografia mostro atrofia cerebral y cavitaciones paraventriculares.


Subject(s)
Adolescent , Humans , Female , Cerebrum , Hepatolenticular Degeneration/physiopathology , Hepatolenticular Degeneration/drug therapy , Hepatolenticular Degeneration/blood , Copper/blood , Copper/metabolism , Hepatolenticular Degeneration/diet therapy , Penicillamine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL